
LIVERAIM is an IHI-funded project focused on developing a biomarker-based personalized risk calculator for the early diagnosis of chronic liver disease. The project aims to shift the paradigm from treating complications to screening and prevention by creating and validating a platform for early detection in asymptomatic individuals, enabling personalized and effective therapeutic interventions. The consortium comprises top academic researchers, industry partners, patient associations, health economists, public health experts, and AI tool creators. They plan to test existing biomarkers and use AI to develop a digital screening platform, which will be validated in a large clinical study of 100,000 subjects. The project also promotes a tool called the LiverRisk score for assessing liver fibrosis.

LIVERAIM is an IHI-funded project focused on developing a biomarker-based personalized risk calculator for the early diagnosis of chronic liver disease. The project aims to shift the paradigm from treating complications to screening and prevention by creating and validating a platform for early detection in asymptomatic individuals, enabling personalized and effective therapeutic interventions. The consortium comprises top academic researchers, industry partners, patient associations, health economists, public health experts, and AI tool creators. They plan to test existing biomarkers and use AI to develop a digital screening platform, which will be validated in a large clinical study of 100,000 subjects. The project also promotes a tool called the LiverRisk score for assessing liver fibrosis.